An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer E PinkertonP GoodJ Hardy Commentary 04 November 2016 Pages: 341 - 343
Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study? Vittorio FuscoAlberto BedogniGiuseppina Campisi Letter to the editor 09 March 2016 Pages: 345 - 349
Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab Paul de BoissieuThierry Trenque Letter to the editor 28 April 2016 Pages: 351 - 352
Response to letter to the Editors—Safety of long-term denosumab therapy Alison T. StopeckDouglas J. Warner Letter to the editor Open access 24 November 2016 Pages: 353 - 355
Photobiomodulation therapy in the management of chronic oral graft-versus-host disease Joel B. EpsteinJudith E. Raber-DurlacherD. Tzachanis Original Article 21 September 2016 Pages: 357 - 364
Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials Eric J. RoelandJoseph D. MaVickie E. Baracos Original Article 15 September 2016 Pages: 365 - 369
Palliative care consultation team on acute wards—an intervention study with pre-post comparisons Maria FriedrichsenYvonne HajradinovicAnna Milberg Original Article Open access 16 September 2016 Pages: 371 - 380
Impact of enhanced recovery program on patients with esophageal cancer in comparison with traditional care Lihong WangChenjing ZhuPing Li Original Article 10 October 2016 Pages: 381 - 389
Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study Noor Al-DasooqiJoanne BowenRachel Gibson Original Article 20 September 2016 Pages: 391 - 398
Lost and stranded: the experience of younger adults with advanced cancer Matthew K. KnoxSarah HalesGary Rodin Original Article 27 September 2016 Pages: 399 - 407
Quality of life (QOL) and symptom burden (SB) in patients with breast cancer Julia HamerRachel McDonaldEdward Chow Original Article 30 September 2016 Pages: 409 - 419
Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all? Lisa BriceNicole GilroyIan Kerridge Original Article 03 October 2016 Pages: 421 - 427
Evaluation of the effects and adverse drug reactions of low-dose dexamethasone premedication with weekly docetaxel Rae Young KangKyung Sook YooYu Jeung Lee Original Article 30 September 2016 Pages: 429 - 437
Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor Derek WeyckerXiaoyan LiGary H. Lyman Original Article 12 October 2016 Pages: 439 - 447
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia Stephen A. SandsBrian T. HarelPeter D. Cole Original Article 10 October 2016 Pages: 449 - 457
Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study Lucksamon ThamlikitkulVichien SrimuninnimitNopadol Soparattanapaisarn Original Article 06 October 2016 Pages: 459 - 464
Axillary web syndrome is not a risk factor for lymphoedema after 10 years of follow-up Bárbara Reis WarissRejane Medeiros CostaAnke Bergmann Original Article 04 October 2016 Pages: 465 - 470
Determining best methods to screen for religious/spiritual distress Stephen D. W. KingGeorge FitchettElizabeth Trice Loggers Original Article 06 October 2016 Pages: 471 - 479
Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity Yoshitaka SaitoMasaki KobayashiKen Iseki Original Article 03 October 2016 Pages: 481 - 487
Pathways between physical activity and quality of life in African-American breast cancer survivors Rachel MeadowsTimethia BonnerRaheem Paxton Original Article 05 October 2016 Pages: 489 - 495
Barriers to lung cancer care: health professionals’ perspectives J. DunnG. GarveyS. K. Chambers Original Article Open access 10 October 2016 Pages: 497 - 504
A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer K. H. ParkS. LeeJae Hong Seo Original Article 06 October 2016 Pages: 505 - 511
Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer Nicole K. BehnkeDustin K. BakerBrent A. Ponce Original Article 04 October 2016 Pages: 513 - 521
Advance directives in patients with advanced cancer receiving active treatment: attitudes, prevalence, and barriers Julie C. McDonaldJeanne M. du ManoirCamilla Zimmermann Original Article 07 October 2016 Pages: 523 - 531
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer Yi-Hsin LiangChih-Hsin WeiKun-Huei Yeh Original Article 04 October 2016 Pages: 533 - 539
Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia Beejal R. GantiBernard L. MariniAnthony J. Perissinotti Original Article 14 October 2016 Pages: 541 - 547
Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications Stefan StefanovicMarkus WallwienerSara Brucker Original Article 17 October 2016 Pages: 549 - 558
A qualitative exploration of oncology nurses’ family assessment practices in Denmark and Australia Elisabeth CoyneKarin B. Dieperink Original Article 10 October 2016 Pages: 559 - 566
Health-related problems in adult cancer survivors: development and validation of the Cancer Survivor Core Set O.P. GeerseK. WyniaA.J. Berendsen Original Article Open access 14 October 2016 Pages: 567 - 574
The impact of a simplified documentation method for the Edmonton classification system for cancer pain (ECS-CP) on clinician utilization Kimberson TancoJoseph ArthurEduardo Bruera Original Article 08 October 2016 Pages: 575 - 580
Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea Thomas KutnerEmily KunkelU. Margaretha Wallon Original Article 12 October 2016 Pages: 581 - 587
Quality of life trajectories after diagnosis of gynecologic cancer: a theoretically based approach Brian D. GonzalezSharon L. ManneMark Morgan Original Article 19 October 2016 Pages: 589 - 598
The role of palliative care in the last month of life in elderly cancer patients Tarek AssiElie El RassyJoseph Kattan Original Article 13 October 2016 Pages: 599 - 605
A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation Midori NakagakiMichael BarrasGlen A. Kennedy Original Article 13 October 2016 Pages: 607 - 613
The Enhancing Connections-Telephone study: a pilot feasibility test of a cancer parenting program Frances Marcus LewisKristin A. GriffithNai-ching Chi Original Article 21 October 2016 Pages: 615 - 623
Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer S. C. Agasi-IdenburgM. S. Y. ThongN. K. Aaronson Original Article 21 October 2016 Pages: 625 - 632
Psychometric properties and measurement equivalence of the English and Chinese versions of the Beck Anxiety Inventory in patients with breast cancer Yu KeTerence NgAlexandre Chan Original Article 22 October 2016 Pages: 633 - 643
The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids Sebastiano MercadanteClaudio AdileAlessandra Casuccio Original Article 15 October 2016 Pages: 645 - 649
Dermatologic events from EGFR inhibitors: the issue of the missing patient voice Bernd TischerRenate HuberMario E. Lacouture Review Article Open access 07 October 2016 Pages: 651 - 660
The use of opioids in cancer patients with renal impairment—a systematic review Tonje A. SandeBarry J. A. LairdMarie T. Fallon Review Article 15 October 2016 Pages: 661 - 675
Do-not-resuscitate orders in cancer patients: a review of literature Aart OsinskiGerard VreugdenhilJohannes G. van der Hoeven Review Article 22 October 2016 Pages: 677 - 685
A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions Sharon EladVinisha RannaViral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) Review Article 16 November 2016 Pages: 687 - 700
